Stockscreener 앱 받기
437.33
0.30%
-1.33
시간 외 거래:
437.33
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
Access Investment Management LLC Makes New $2.14 Million Investment in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Position Lessened by Bessemer Group Inc. - MarketBeat
Combining machine learning predictions for United Therapeutics CorporationMarket Performance Recap & Verified Technical Trade Signals - newser.com
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease - The Joplin Globe
United Therapeutics (Nasdaq: UTHR) starts EXPAND with first UKidney xenotransplant - Stock Titan
Can technical indicators confirm United Therapeutics Corporation’s reversalWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of Stock - MarketBeat
United Therapeutics Hits Day High with 9.63% Surge in Stock Price - Markets Mojo
Is United Therapeutics Corporation (UTH) stock a top dividend aristocrat candidateRisk Management & Reliable Entry Point Trade Alerts - newser.com
MSN Money - MSN
United Therapeutics Corp. Hits New 52-Week High of $479.50 - Markets Mojo
United Therapeutics posts record revenue but misses Q3 earnings expectations - MSN
Focus Partners Advisor Solutions LLC Buys Shares of 1,440 United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation - MSN
United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
3rd Circ. Preview: BMW, MiLB And Sandoz Top Nov. Lineup - Law360
United Therapeutics (NASDAQ:UTHR) Given New $423.00 Price Target at Wells Fargo & Company - MarketBeat
Assetmark Inc. Boosts Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat
Will United Therapeutics Corporation stock benefit from upcoming earnings reportsOptions Play & Technical Pattern Alert System - newser.com
United Therapeutics Executives Sell Shares - TradingView
United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Wells Fargo Maintains United Therapeutics (UTHR) Equal-Weight Recommendation - Nasdaq
United Therapeutics (NASDAQ:UTHR) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat
United Therapeutics price target raised to $587 from $569 at RBC Capital - TipRanks
United Therapeutics price target raised to $447 from $435 at Morgan Stanley - TipRanks
United Therapeutics (UTHR) Earnings Transcript - AOL.com
United Therapeutics Corporation (NASDAQ:UTHR) Q3 2025 Earnings Call Transcript - Insider Monkey
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - MSN
United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - MSN
Silver Spring-based United Therapeutics reports Q3 earnings - Maryland Daily Record
Published on: 2025-10-31 23:58:52 - newser.com
United Therapeutics Reports Record Q3 2025 Results - TipRanks
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus
United Therapeutics: Q3 Earnings Snapshot - CT Insider
United Therapeutics (NASDAQ:UTHR) COO Sells $9,393,750.00 in Stock - MarketBeat
Why Is United Therapeutics (UTHR) Stock Soaring Today - Yahoo Finance
United Therapeutics Q3 Earnings Beat Estimates, Revenues Miss Mark - TradingView
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday - Benzinga
United Therapeutics Q3 2025 Earnings ReportRevenue & Profit AnalysisNews and Statistics - IndexBox
United Therapeutics Q3 2025 Earnings: Profit Beats ForecastsNews and Statistics - IndexBox
United Therapeutics (UTHR) Beats Q3 Earnings Estimates - Yahoo Finance
United Therapeutics Grows Revenue, But Misses Earnings Forecast - Finimize
United Therapeutics Corp Q3 2025 Earnings: EPS of $7.16 Beats Es - GuruFocus
United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings - Yahoo Finance
United Therapeutics Corp Announces Rise In Q3 Bottom Line - Nasdaq
United Therapeutics misses Q3 expectations despite record revenue - Investing.com
United Therapeutics misses Q3 expectations despite record revenue By Investing.com - Investing.com Philippines
United Therapeutics Q3 revenue misses estimates - TradingView
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results - TradingView
UNITED THERAPEUTICS Corp SEC 10-Q Report - TradingView
Sumitomo Mitsui Trust Group Inc. Has $28.81 Million Holdings in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics Corporation $UTHR Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
United Therapeutics Corporation $UTHR Shares Sold by Nisa Investment Advisors LLC - MarketBeat
United Therapeutics Corp. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Will United Therapeutics Corporation stock outperform value stocksTrade Performance Summary & Community Verified Swing Trade Signals - fcp.pa.gov.br
Can United Therapeutics Corporation stock resist sector downturnsPortfolio Risk Summary & AI Enhanced Market Trend Forecasts - fcp.pa.gov.br
0.29%
0.87%
자본화:
|
볼륨(24시간):